Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

INTRODUCTION: Ebola virus disease (EVD) continues to be a significant public health problem in sub-Saharan Africa, especially in the Democratic Republic of the Congo (DRC). Large-scale vaccination during outbreaks may reduce virus transmission. We established a large population-based clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson-Jones, Deborah, Kavunga-Membo, Hugo, Grais, Rebecca F, Ahuka, Steve, Roberts, Natalie, Edmunds, W John, Choi, Edward M, Roberts, Chrissy H, Edwards, Tansy, Camacho, Anton, Lees, Shelley, Leyssen, Maarten, Spiessens, Bart, Luhn, Kerstin, Douoguih, Macaya, Hatchett, Richard, Bausch, Daniel G, Muyembe, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905941/
https://www.ncbi.nlm.nih.gov/pubmed/35260458
http://dx.doi.org/10.1136/bmjopen-2021-055596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905941/
https://www.ncbi.nlm.nih.gov/pubmed/35260458
http://dx.doi.org/10.1136/bmjopen-2021-055596

Ejemplares similares